| Comparison of open-source reverse vaccinology programs for bacterial vaccine antigen discovery M Dalsass, A Brozzi, D Medini, R Rappuoli Frontiers in immunology 10, 431583, 2019 | 125 | 2019 |
| Genome-Based Approach Delivers Vaccine Candidates Against Pseudomonas aeruginosa I Bianconi, B Alcala-Franco, M Scarselli, M Dalsass, S Buccato, ... Frontiers in immunology 9, 3021, 2019 | 43 | 2019 |
| Integrated requirement of non‐specific and sequence‐specific DNA binding in Myc‐driven transcription P Pellanda, M Dalsass, M Filipuzzi, A Loffreda, A Verrecchia, ... The EMBO journal 40 (10), e105464, 2021 | 25 | 2021 |
| Commensal Bifidobacterium Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines M Tomasi, M Dalsass, F Beghini, I Zanella, E Caproni, L Fantappiè, ... Vaccines 9 (11), 1356, 2021 | 16 | 2021 |
| Retrospective Identification of a Broad IgG Repertoire Differentiating Patients With S. aureus Skin and Soft Tissue Infections From Controls F Rigat, E Bartolini, M Dalsass, N Kumar, S Marchi, P Speziale, D Maione, ... Frontiers in Immunology 10, 114, 2019 | 13 | 2019 |
| Outer membrane vesicles from the gut microbiome contribute to tumor immunity by eliciting cross-reactive T cells M Tomasi, E Caproni, M Benedet, I Zanella, S Giorgetta, M Dalsass, ... Frontiers in Oncology 12, 912639, 2022 | 9 | 2022 |
| Polycomb group ring finger protein 6 suppresses Myc-induced lymphomagenesis N Tanaskovic, M Dalsass, M Filipuzzi, G Ceccotti, A Verrecchia, P Nicoli, ... Life Science Alliance 5 (8), 2022 | 4 | 2022 |
| STRAIN: an R package for multi-locus sequence typing from whole genome sequencing data M Dalsass, M Bodini, C Lambert, MC Mortier, M Romanelli, D Medini, ... BMC bioinformatics 20, 1-8, 2019 | 1 | 2019 |
| GENOME-BASED APPROACH DELIVERS NOVEL VACCINE CANDIDATES AGAINST PSEUDOMONAS AERUGINOSA B Alcala-Franco, I Bianconi, M Scarselli, M Dalsass, V Masignani, ... PEDIATRIC PULMONOLOGY 53, 295-295, 2018 | | 2018 |
| Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells M Bellone, Q Kong, AG Goubet, U Genève, G Grandi, A Grandi, M Tomasi, ... | | |
Duccio MediniR3 Program Director, Wellcome LeapVerified email at wellcomeleap.org
